Back to Journals » OncoTargets and Therapy » Volume 14

Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report

Total article views   Abstract views HTML views PDF downloads Totals
653 Dovepress* 415 238+ 96 653
Totals 415 238 96 653
*Since 25 March 2021
+Since July 2016

View citations on Google Scholar